Wednesday, 28 June 2017

Singapore News

  • A*Star man becomes first non-EU scientist to win EMBO YIP award

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 19 Nov, 2012

    Singapore: Dr Bruno Reversade from A*STAR's Institute of Medical Biology (IMB) is the first scientist, based outside Europe, to have been awarded the prestigious European Molecular Biology...Read more

  • Singapore develops animal-free screening platform to predict nephrotoxicity

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2015

    Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-free screening platforms capable of predicting the toxic effects of com...Read more

  • Future of Healthcare in Asia

    Singapore |  Analysis | By Amrita Tejasvi | 0 Comment | 05 May, 2014

    Healthcare industry is in a period of evolution accelerated by changing demographics and market forces propelled by insurge of healthcare awareness, availability of technology and fast acce...Read more

  • Alcon invests $159 mn in eye drug plant in Singapore

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2014

    Singapore: Alcon, global eye care firm, has launched an ophthalmic pharmaceutical manufacturing facility in Singapore to produce ophthalmic pharmaceutical products which address eye conditi...Read more

  • F&S: Private hospital sector to grow in APAC

    Singapore |  Analysis | By BioSpectrum Bureau | 0 Comment | 07 Feb, 2013

    Singapore: About 180 million new hospital beds will be needed over the next decade to meet the rising healthcare demand in Asia Pacific, more than 40 percent of which is expected to come fr...Read more

  • Health Sciences Authority signs MoU to promote public health

    Singapore |  Regulatory | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2012

    Singapore: Singapore's Health Sciences Authority has signed a memorandum of understanding (MoU) with the National University of Singapore's Saw Swee Hock School of Public Health (SSHSPH). T...Read more

  • A*Star peptides help understand Alzheimer's, cancer

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013

    Singapore: A new class of ultrasmall peptides developed by A*Star's Institute of Bioengineering and Nanotechnology (IBN) is providing scientists a platform for understanding degenerative di...Read more

  • Mundipharma buys Merck's ophthalmology business

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2015

    Singapore: Mundipharma Ophthalmology Products has announced an agreement with MSD, known as Merck in the United States and Canada, to acquire MSD's ophthalmology portfolio for the treatment...Read more

  • IBM, A*Star co-develop anti-microbial hydrogel

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 24 Jan, 2013

    Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-ever antimicrobial hydrogel that can break apart biofilms and destroy ...Read more

  • Pfizer launches targeted therapy for lung cancer in Singapore

    Singapore |  Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2015

    Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singapore. Xalkori is used to treat patients with late-stage (locally adv...Read more

  • Singapore market forecast

    Singapore |  Opinion | By BioSpectrum Bureau | 0 Comment | 19 Jan, 2016

    Singapore: Over the past 15 years, Singapore has developed into a renowned bioscience cluster through top-down investment in world-class infrastructure and skilled talent for R&D and bi...Read more

  • HSA nod for Aslan rheumatoid arthritis drug

    Singapore |  Regulatory | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013

    Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Trial Certificate Application for ASLAN003, which is a novel oral small ...Read more

  • Covance recieves Frost and Sullivan Award

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2014

    Singapore: Covance, a global drug development company, has recieved the 2014 Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award, for its business performance and conti...Read more

  • Challenge No 5: Talent trouble

    Singapore |  Analysis | By Narayan Kulkarni | 0 Comment | 17 May, 2012

    Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key positions are problems in certain regions, especially for conducting R&...Read more

  • BI shows afatinib to be effective in advanced squamous cell carcinoma of lung

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2015

    Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in patients with advanced squamous cell carcinoma (SCC) of the lung. The...Read more

  • BMS reacquires rights to oncology drug from Asia Partner

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2016

    Singapore: ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents for Asia-prevalent tumour types, today announced that Bristol-M...Read more

  • ICON appoints APAC and Japan VPs

    Singapore |  News | By BioSpectrum Bureau | 0 Comment | 03 Nov, 2015

    Singapore: ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has appointed Ms Mary Pan as vice president...Read more

  • Personalized medicine market to reach $149 bn by 2020

    Singapore |  Analysis | By BioSpectrum Bureau | 0 Comment | 10 Feb, 2016

    Singapore: Personalized medicine market will be worth over USD149 billion by 2020, growing at a CAGR of 8.74 percent, and will be driven by oncology, cardiovascular and infectious disease t...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls